| Pharmaceutical Information |
| Drug Name |
Quazepam |
| Drug ID |
BADD_D01887 |
| Description |
Quazepam is a drug which is a benzodiazepine derivative. It induces impairment of motor function and has hypnotic properties. Quazepam is used to treat insomnia. |
| Indications and Usage |
Used to treat insomnia. |
| Marketing Status |
approved; illicit |
| ATC Code |
N05CD10 |
| DrugBank ID |
DB01589
|
| KEGG ID |
D00457
|
| MeSH ID |
C025130
|
| PubChem ID |
4999
|
| TTD Drug ID |
D03NPH
|
| NDC Product Code |
71993-265; 61825-165; 53883-5783 |
| UNII |
JF8V0828ZI
|
| Synonyms |
quazepam | Quiedorm | Doral | Sch 16134 | Sch-16134 |
|
| Chemical Information |
| Molecular Formula |
C17H11ClF4N2S |
| CAS Registry Number |
36735-22-5 |
| SMILES |
C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
